CA-TRADESHIFT
10.2.2020 15:02:12 CET | Business Wire | Press release
Tradeshift, the leader in supply chain payments and marketplaces, has announced the addition of four new hires hailing from Microsoft, Ariba, SAP and Oracle. On the heels of Tradeshift’s latest funding news, in which the company announced $240 million in funding, the company welcomes these seasoned veterans to help the company reach its strategic goals for 2020.
The four new hires represent deep experience in a range of business leadership initiatives including network, product and sales. The roles include:
Janet Heppner-Jones, VP of North America Sales : Heppner-Jones has an impressive background in digital solutions and SaaS sales leadership, most recently leading the America's sales team at Baker Hughes. Her diverse background has provided her with global executive responsibilities in many multinational companies across many business functions, including SAP, ABB, Dassault Systems, and Ariba. Heppner-Jones began her career as a Sales Representative with IBM where she earned the prestigious Eagle Award (top 1% of the sales force). At Tradeshift, Heppner-Jones will continue and accelerate the 60 percent growth rate, increase deal size, and work with partners in North America.
Tony Alvarez, VP of Network : Alvarez will be responsible for Tradeshift seller onboarding, GMV growth, and the Tradeshift early payment and Marketplace offerings. Prior to joining, Alvarez spent 10 years with SAP Ariba serving in several senior leadership positions in the commercial and operational functions, most recently serving as SVP of Ariba Business Network Solutions. He has experience in large deal negotiations, network monetization, and marketplace development. Alvarez began his career with Arthur Andersen Consulting, then went on to earn his MBA at Harvard.
Henry Goh, VP of APAC Sales: Goh will be leading all APAC sales as the VP of Sales, APAC. For the past 10 years, Goh has been running APAC sales for Ariba. Prior to Ariba, he was at PwC and Oracle leading teams across Asia. Goh has a wealth of experience in “go-to-market” strategy in APAC. He has experience in large deal negotiations including cultivating, developing, formulating and constructing deals.
Raphael Bres, Chief Product Officer: Bres brings to Tradeshift over 20 years experience building ERP’s at Workday, FinancialForce, and Peoplesoft, built on a solid foundation from Deloitte, Oracle and Microsoft. While Bres will be based out of our San Francisco office, he also brings strong global experience, having not only held international roles but also earning his graduate degrees from Université Paris Dauphine.
“This is a pivotal year for Tradeshift and we’re hyper-focused on the areas of the business that will give us the greatest momentum and lead us to profitability,” said Christian Lanng, CEO of Tradeshift. “With a combined 70 years of experience, Janet, Tony, Henry and Raphael will successfully lead the charge on tackling the aggressive and ambitious goals we have set out for ourselves and will no doubt make this the most successful year we’ve seen at Tradeshift.”
About Tradeshift
Tradeshift drives supply chain innovation for the digitally connected economy. As the leader in supply chain payments and marketplaces, the company helps buyers and suppliers digitize all their trade transactions, collaborate on every process, and connect with any supply chain app. More than 1.5 million companies across 190 countries trust Tradeshift to process over half a trillion USD in transaction value, making it the largest global business network for buying and selling. Discover commerce for all at tradeshift.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200210005298/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom